Nadhan Revathy, Vaman Jayashree V, C Nirmala, Kumar Sengodan Satheesh, Krishnakumar Hemalatha Sreelatha, Rajan Arathi, Varghese Geetu Rose, Rl Neetha, Bv Amritha Krishna, Thankappan Ratheeshkumar, Srinivas Priya
Cancer Research Program 5, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.
Department of Obstetrics and Gynecology, SAT Hospital, Government Medical College, Thiruvananthapuram, Kerala, India.
Crit Rev Oncol Hematol. 2017 Jun;114:77-90. doi: 10.1016/j.critrevonc.2017.04.001. Epub 2017 Apr 7.
Gestational trophoblastic diseases (GTD) encompass a group of placental tumors which mostly arise due to certain fertilization defects, resulting in the over-proliferation of trophoblasts. The major characteristic of this diseased state is that β-hCG rises up manifold than that is observed during pregnancy. The incidence of GTD when analyzed on a global scale, figures out that there is a greater risk in South-East Asia, the reason of which remains unclear. An insight into any possible correlation of GTD incidence with cancers, other than choriocarcinoma, is being attempted here. Also, we review the recent developments in research on the molecular etiopathology of GTD. This review would render a wider eye towards a new paradigm of thoughts to connect GTD and breast cancer, which has not been into the picture till date.
妊娠滋养细胞疾病(GTD)是一组胎盘肿瘤,主要由某些受精缺陷引起,导致滋养细胞过度增殖。这种疾病状态的主要特征是β-人绒毛膜促性腺激素(β-hCG)比孕期观察到的水平升高数倍。从全球范围分析GTD的发病率发现,东南亚地区的风险更高,其原因尚不清楚。本文试图深入探讨GTD发病率与除绒毛膜癌以外的其他癌症之间的可能关联。此外,我们还综述了GTD分子病因病理学研究的最新进展。这篇综述将为连接GTD和乳腺癌的新思维模式提供更广阔的视野,而这一模式迄今尚未出现。